Cargando…
When a joint model should be preferred over a linear mixed model for analysis of longitudinal health-related quality of life data in cancer clinical trials
BACKGROUND: Patient-reported outcomes such as health-related quality of life (HRQoL) are increasingly used as endpoints in randomized cancer clinical trials. However, the patients often drop out so that observation of the HRQoL longitudinal outcome ends prematurely, leading to monotone missing data....
Autores principales: | Touraine, Célia, Cuer, Benjamin, Conroy, Thierry, Juzyna, Beata, Gourgou, Sophie, Mollevi, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912607/ https://www.ncbi.nlm.nih.gov/pubmed/36765307 http://dx.doi.org/10.1186/s12874-023-01846-3 |
Ejemplares similares
-
Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17
por: Cuer, B., et al.
Publicado: (2020) -
Development of a Clinical–Biological Model to Assess Tumor Progression in Metastatic Pancreatic Cancer: Post Hoc Analysis of the PRODIGE4/ACCORD11 Trial
por: Egea, Julie, et al.
Publicado: (2022) -
Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials
por: Barbieri, Antoine, et al.
Publicado: (2017) -
Should ecologists prefer model‐ over distance‐based multivariate methods?
por: Jupke, Jonathan F., et al.
Publicado: (2020) -
GUIP1: a R package for dose escalation strategies in phase I cancer clinical trials
por: Dinart, D., et al.
Publicado: (2020)